首页 > 新书资源
新书资源(2017年12月)

Human stem cell toxicology / edited by James L. Sherley, Asymmetrex, LLC, Boston, MA, USA. -- Cambridge, UK : Royal Society of Chemistry, 2016. – (58.155/H918s)

Contents

Chapter 1  Addressing Challenges to Progress in Human Stem Cell Toxicology Concepts and Practice

1.1  Filling in the Stem Cell Gap in Human Toxicology

1.2  Historical Impact of the Hierarchical, Anatomical, Sub-disciplinary Structure of Toxicological Sciences

1.3  Human Stem Cell Toxicology as a Stem Cell Exact Science

1.4  Health and Medical Applications for Human Stem Cell Toxicological Sciences

1.5  Introducing the Future Diverse Impacts of Human Stem Cell Toxicology

Acknowledgements

References

Chapter 2  Alternative Methods in Haematopoietic Stem Cell Toxicology

2.1  Introduction

2.2  Haematopoietic Stem Cell Toxicity or Hematotoxicity

2.3  Colonogenic Assays as Predictors of Haematopoietic Stem Cell Toxicity

2.4  Conclusions

Acknowledgements

References

Chapter 3  High-throughput Screening of Toxic Chemicals on Neural Stem Cells

3.1  Neural Stem Ceils

3.2  Toxic Chemicals in the Environment

3.3  Mechanisms of Neural Stem Cell Toxicity

3.4  NSC Differentiation

3.5  Conventional In vitro Assays for Toxicity Screening against Neural Stem Cells

3.6  Challenges of Conventional In vitro Approaches in Neurotoxicity Screening

3.7  Conclusions and Future Directions

Acknowledgements

References

Chapter 4  The Role of Catecholamines in Stem Cell Mobilisation

4.1  Introduction

4.2  Catecholamines

4.3  Catecholamines and Stem Cell Mobilisation

4.4  Consequences of Catecholamine-modulating Agents for Stem Cell Toxicity

4.5  Concluding Comments

References

Chapter 5  Toxicological Risk Assessment - Proposed Assay Platform Using Stem and Progenitor Cell Differentiation in Response to Environmental Toxicants

5.1  Introduction

5.2  Environmental Toxicological Risk Assessment Employing an Assay Platform That Uses Stem and Progenitor Cell Differentiation

5.3  Current State of ECF Platform Development

5.4  Bioanalytical Method Validation

5.5  Final Thoughts

References

Chapter 6  Current Developments in the Use of Human Stem Cell Derived Cardiomyocytes to Examine Drug-induced Cardiotoxicity

6.1  Introduction

6.2  Constraints Due to Species Differences

6.3  Stem Cells and iPSC-CMs

6.4  Limitations with Stem Cells

6.5  Stem Cells in Cardiovascular Safety Pharmacology

6.6  Disease Models Based on iPSC-CMs

6.7  Generation of iPSC-CMs - Considerations on Differentiation, Maturity, Heterogeneity and Purification Protocols

6.8  Use of iPSC-CMs in Phenotypic Assays

6.9  Assay Technologies Incorporating iPSC-CMs and hESC-CMs

6.10  CiPA: Comprehensive In vitro Proarrhythmia Assay

6.11  Conclusion

References

Chapter 7  Pesticides and Hematopoietic Stem Cells

7.1  Pesticide Toxicity-induced Disorders of Hematopoietic System

7.2  Pesticide Toxicity on Hematopoietic Stem Cells and their Microenvironment

7.3  Experimental Medicine Against Pesticide Toxicity-induced Hematopoietic Failure

7.4  Future Direction

References

Chapter 8  Epigenetic Impact of Stem Cell Toxicants

8.1  Introduction

8.2  Epigenetic Regulation of Stem Cells

8.3  Stem Cell Toxicants as Modulators of Epigenetic Programming

8.4  Conclusion

Acknowledgements

References

Chapter 9  Metakaryotic Cancer Stem Cells are Constitutively Resistant to X-Rays and Chemotherapeutic Agents, but Sensitive to Many Common Drugs

9.1  Introduction

9.2  Materials and Methods

9.3  Results

9.4  Discussion

Acknowledgements

References

Chapter 10 Distributed Stem Cell Kinetotoxicity: A New Concept to Account for the Human Carcinogenicity of Non-genotoxie Environmental Toxicants

10.1  Introduction

10.2  Results and Discussion

10.3  Conclusions and Closing Thoughts

10.4  Materials and Methods

Acknowledgements

References

Chapter 11 Cancer Stem Cells as Therapeutic Targets

11.1  Introduction

11.2  CSC Markers and Therapeutic Targets

11.3  Signal Transduction in CSCs and Targeted Agents

11.4  Asymmetric Cell Divisions: The Dilemma of Studies on CSCs

11.5  Asymmetric Cell Divisions: Visualization of CSCs and Toxicology

11.6  Asymmetric Cell Divisions; Potential Therapeutics Targeting CSCs

11.7  Closing Remarks

Acknowledgements

References

Subject Index